93 related articles for article (PubMed ID: 24030986)
1. Translating antibody insights.
Gerberding JL
Science; 2013 Sep; 341(6151):1151. PubMed ID: 24030986
[No Abstract] [Full Text] [Related]
2. Antibodies, viruses and vaccines.
Burton DR
Nat Rev Immunol; 2002 Sep; 2(9):706-13. PubMed ID: 12209139
[TBL] [Abstract][Full Text] [Related]
3. Editorial overview: Preventive and therapeutic vaccines (B cell epitope vaccine).
Law M
Curr Opin Virol; 2015 Apr; 11():viii-x. PubMed ID: 26003398
[No Abstract] [Full Text] [Related]
4. AIDS/HIV. A boost for HIV vaccine design.
Burton DR; Weiss RA
Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840
[No Abstract] [Full Text] [Related]
5. Super antibody may have the potential to both prevent and cure flu.
Breeze S
Immunotherapy; 2012 Nov; 4(11):1093-4. PubMed ID: 23326919
[No Abstract] [Full Text] [Related]
6. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
[TBL] [Abstract][Full Text] [Related]
7. Strategies to guide the antibody affinity maturation process.
Doria-Rose NA; Joyce MG
Curr Opin Virol; 2015 Apr; 11():137-47. PubMed ID: 25913818
[TBL] [Abstract][Full Text] [Related]
8. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA
Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341
[TBL] [Abstract][Full Text] [Related]
9. The early cellular signatures of protective immunity induced by live viral vaccination.
Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
[TBL] [Abstract][Full Text] [Related]
10. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
[TBL] [Abstract][Full Text] [Related]
11. Genital delivery of virus-like particle and pseudovirus-based vaccines.
Cuburu N; Chackerian B
Expert Rev Vaccines; 2011 Sep; 10(9):1245-8. PubMed ID: 21919611
[TBL] [Abstract][Full Text] [Related]
12. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting.
Sundling C; Martinez P; Soldemo M; Spångberg M; Bengtsson KL; Stertman L; Forsell MN; Karlsson Hedestam GB
J Infect Dis; 2013 Feb; 207(3):426-31. PubMed ID: 23162135
[TBL] [Abstract][Full Text] [Related]
13. GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.
Costers S; Vanhee M; Van Breedam W; Van Doorsselaere J; Geldhof M; Nauwynck HJ
Virus Res; 2010 Dec; 154(1-2):104-13. PubMed ID: 20837070
[TBL] [Abstract][Full Text] [Related]
14. [Current vaccination strategies].
Dietz K
Internist (Berl); 1992 Sep; 33(9):575-80. PubMed ID: 1399392
[No Abstract] [Full Text] [Related]
15. A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease.
Campo MS; O'Neil BW; Grindlay GJ; Curtis F; Knowles G; Chandrachud L
Virology; 1997 Aug; 234(2):261-6. PubMed ID: 9268157
[TBL] [Abstract][Full Text] [Related]
16. Unconventional vaccines: immunization with anti-idiotype antibody against viral diseases.
Koprowski H
Cancer Res; 1985 Sep; 45(9 Suppl):4689s-4690s. PubMed ID: 2990707
[No Abstract] [Full Text] [Related]
17. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Mucosal Immunity for Antiviral Vaccines.
Iwasaki A
Annu Rev Immunol; 2016 May; 34():575-608. PubMed ID: 27168245
[TBL] [Abstract][Full Text] [Related]
19. Mapping the journey to an HIV vaccine.
Ackerman M; Alter G
N Engl J Med; 2013 Jul; 369(4):389-91. PubMed ID: 23883384
[No Abstract] [Full Text] [Related]
20. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.
Walker LM; Burton DR
Nat Rev Immunol; 2018 May; 18(5):297-308. PubMed ID: 29379211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
